The open index of psychedelic research

Psilocybin-Assisted Therapy for Intergenerational Trauma

Effects of MDMA-Assisted Therapy on Depressive Symptoms in Posttraumatic Stress Disorder: A Systematic Review and Meta-Analysis

Development of a Physiologically Based Pharmacokinetic/Pharmacodynamic Model of Psilocybin/Psilocin from Psilocybe cubensis (Magic Mushroom) in Treatment-Resistant Depression.

Thaoboonruang N, Tan YM, Lohitnavy O +3

Effect of Sub-Anesthetic Dose Esketamine on Oculocardiac Reflex in Children Undergoing Day-Case Strabismus Surgery: A Randomized Controlled Trial.

Lei G, Liu J, Yang S +2

Esketamine for Pediatric Emergence Delirium: Is the Evidence Conclusive?

Mistry T, Nair AS

Therapeutic Prospects of Ketamine for Cataplexy in Narcolepsy Type 1: Evidence from a Human Case and a Murine Model.

Ricordeau F, Arthaud S, Langbour L +6

Oregon's state-regulated psilocybin services: Early real-world safety signals.

Luoma JB, Chwyl C, Des Jarlais D +6

Psychedelics in the treatment of anorexia nervosa: a systematic review and meta-analysis

Psychedelics in the treatment of anorexia nervosa: a systematic review and meta-analysis

Psychedelics in the treatment of anorexia nervosa: a systematic review and meta-analysis

Broad-spectrum LC-MS/MS hair analysis for monitoring recreational drug use in electronic dance music festival attendees.

Pereira Dos Santos B, de Souza Schwarz P, Birk L +3

Eight years of nationwide routine wastewater surveillance in New Zealand: Demonstrating its complementary role in public health policy.

Van Wichelen N, Cliff M, Orton A +9

A neuro-computational approximation of the qualities of mental images

Stecher R, Kaiser D

A dominant frontoparietal beta oscillatory brain state in the days after psilocybin and 5-MeO-DMT

West CL, Baker BT, Duran A +4

Clinical suspicion versus toxicological findings in psychoactive substance poisonings: evidence from emergency cases in Brazil (2023-2024).

Bueno Faria Dos Santos NC, Lanaro R, Soubhia PC +4

Pilot study comparing the effects of high dose THC to high dose psilocybin and placebo in the set and setting of a classic psychedelic therapy session.

Barrett FS, Wolinsky D, Daily Z +3

“Am I a candidate for magic mushrooms?” A mystery shopper study of Oregon psilocybin service centers

Efficacy and tolerability of ketamine in moderate to severe obsessive-compulsive disorder: a systematic review.

Eghdami S, Boroon M, Keshavarz-Akhlaghi AA +1

Psilocybin enhances sociability only in altered behavioural state and does not need an awake experience to be effective.

Song C, Chang T, Buchborn T +1

Intraoperative esketamine for postoperative analgesia and depression in pancreatic cancer surgery: protocol for a multicenter randomized controlled trial.

Chong YZ, Sun YE, Ma X +7

Erratum to "Long-term treatment with esketamine nasal spray in patients with treatment resistant depression: Results from the ESCAPE-LTE study" [European Neuropsychopharmacology 107 (2026) 112801].

Reif A, Anıl YA, Bitter I +11

Longitudinal changes in depressive symptoms following naturalistic ayahuasca use: A prospective cohort study in Las Vegas, Nevada

Whitley K, Castellarin K, Dave K +7

Ketamine and Sodium Selenite Promote Transient Receptor Potential Vanilloid 1-Associated Calcium Signaling and Apoptosis in SH-SY5Y Neuroblastoma Cells.

Aladag E, Ovey IS

Synthesis and Analytical Characterization of 1-(1,2-Dimethylcyclobutane-1-Carbonyl)-Lysergic Acid Diethylamide (1D-LSD) and Differentiation From 1-(Thiophene-2-Carbonyl)-LSD (1T-LSD).

Okada Y, Yamamuro T, Kuwayama K +5